Cereno Scientific announces that Redeye initiates equity research coverage of company
Cereno Scientific (XSAT: CRNO B) today announced that Redeye has been engaged by Cereno to produce regular, in-depth equity research reports on the company. The primary purpose is to raise the visibility of Cereno as well as enable investors and shareholders to develop an improved understanding of the business.Redeye is specialized on innovative and Nordic companies within Life Science and Technology. The initial coverage report is now published and available on Cereno’s website, www.cerenoscientific.com, as well as on Redeye’s website, www.redeye.se/company/cereno-scientific. For